HDT 104
Alternative Names: HDT-104Latest Information Update: 29 Apr 2021
At a glance
- Originator HDT Bio
- Class Antineoplastics; Immunotherapies; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Ovarian cancer